Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 7Phase 3 6Phase 1/2 5Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

gallium Ga 68 dotatate 690Y-octreotide, DOTA-Tyr(3)- 3Single Photon Emission Computed Tomography Computed Tomography 2Magnetic Resonance Spectroscopy 23-Iodobenzylguanidine 2lutetium Lu 177 dotatate 1lanreotide 1Tomography, X-Ray Computed 1Tomography, Emission-Computed, Single-Photon 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Metformin 1Iodine-123 1Ga(III)-DOTATOC 168Ga-pentixafor 168Ga-FAPI 164Cu-SARTATE 13-fluorobenzylguanidine 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × lutetium Lu 177 dotatate × NET × Clear all
NCT04544098 2026-05-07

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
10 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡